{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:28:38Z","timestamp":1793780918658,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Cancerfonden (SE)"},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13287-017-0582-6","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T07:28:46Z","timestamp":1503646126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications"],"prefix":"10.1186","volume":"8","author":[{"given":"Roksana","family":"Moraghebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnete","family":"Kirkeby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger E.","family":"R\u00f6nn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Sitnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels-Bjarne","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,25]]},"reference":[{"key":"582_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-8722-5-19","volume":"5","author":"S Wang","year":"2012","unstructured":"Wang S, Qu X, Zhao RC. Clinical applications of mesenchymal stem cells. J Hematol Oncol. 2012;5:19.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"582_CR2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32(3):252\u201360.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"582_CR3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.imlet.2015.05.004","volume":"168","author":"K Blanc Le","year":"2015","unstructured":"Le Blanc K, Davies LC. Mesenchymal stromal cells and the innate immune response. Immunol Lett. 2015;168(2):140\u20136.","journal-title":"Immunol Lett"},{"issue":"5","key":"582_CR4","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/trf.12421","volume":"54","author":"RR Sharma","year":"2014","unstructured":"Sharma RR, et al. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. 2014;54(5):1418\u201337.","journal-title":"Transfusion"},{"issue":"6","key":"582_CR5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/aps.2013.50","volume":"34","author":"X Wei","year":"2013","unstructured":"Wei X, et al. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013;34(6):747\u201354.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"582_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood-2014-04-572255","volume":"125","author":"A Reinisch","year":"2015","unstructured":"Reinisch A, et al. Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation. Blood. 2015;125(2):249\u201360.","journal-title":"Blood"},{"issue":"1","key":"582_CR7","doi-asserted-by":"crossref","first-page":"e000027","DOI":"10.1136\/bmjresp-2014-000027","volume":"1","author":"S Rolandsson","year":"2014","unstructured":"Rolandsson S, et al. Primary mesenchymal stem cells in human transplanted lungs are CD90\/CD105 perivascularly located tissue-resident cells. BMJ Open Respir Res. 2014;1(1):e000027.","journal-title":"BMJ Open Respir Res"},{"key":"582_CR8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fimmu.2014.00205","volume":"5","author":"M Khoury","year":"2014","unstructured":"Khoury M, et al. The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy. Front Immunol. 2014;5:205.","journal-title":"Front Immunol"},{"issue":"Pt 11","key":"582_CR9","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","volume":"119","author":"ML Silva da","year":"2006","unstructured":"da Silva ML, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119(Pt 11):2204\u201313.","journal-title":"J Cell Sci"},{"issue":"5","key":"582_CR10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294\u2013301.","journal-title":"Stem Cells"},{"issue":"2","key":"582_CR11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tibtech.2004.12.003","volume":"23","author":"BM Strem","year":"2005","unstructured":"Strem BM, Hedrick MH. The growing importance of fat in regenerative medicine. Trends Biotechnol. 2005;23(2):64\u20136.","journal-title":"Trends Biotechnol"},{"issue":"12","key":"582_CR12","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.E02-02-0105","volume":"13","author":"PA Zuk","year":"2002","unstructured":"Zuk PA, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279\u201395.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"582_CR13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/14653240701218516","volume":"9","author":"T Gentry","year":"2007","unstructured":"Gentry T, et al. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. Cytotherapy. 2007;9(3):259\u201374.","journal-title":"Cytotherapy"},{"issue":"8","key":"582_CR14","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.exphem.2008.03.004","volume":"36","author":"A Sorrentino","year":"2008","unstructured":"Sorrentino A, et al. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol. 2008;36(8):1035\u201346.","journal-title":"Exp Hematol"},{"issue":"3","key":"582_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mad.2007.12.002","volume":"129","author":"A Stolzing","year":"2008","unstructured":"Stolzing A, et al. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129(3):163\u201373.","journal-title":"Mech Ageing Dev"},{"issue":"8","key":"582_CR16","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood-2009-05-219907","volume":"115","author":"K Tarte","year":"2010","unstructured":"Tarte K, et al. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood. 2010;115(8):1549\u201353.","journal-title":"Blood"},{"issue":"5","key":"582_CR17","doi-asserted-by":"crossref","first-page":"e2213","DOI":"10.1371\/journal.pone.0002213","volume":"3","author":"W Wagner","year":"2008","unstructured":"Wagner W, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One. 2008;3(5):e2213.","journal-title":"PLoS One"},{"issue":"5","key":"582_CR18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1634\/stemcells.22-5-675","volume":"22","author":"MA Baxter","year":"2004","unstructured":"Baxter MA, et al. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells. 2004;22(5):675\u201382.","journal-title":"Stem Cells"},{"issue":"4","key":"582_CR19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbmt.2011.07.023","volume":"18","author":"L Bahr von","year":"2012","unstructured":"von Bahr L, et al. Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol Blood Marrow Transplant. 2012;18(4):557\u201364.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"582_CR20","first-page":"1017","volume":"91","author":"LL Lu","year":"2006","unstructured":"Lu LL, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91(8):1017\u201326.","journal-title":"Haematologica"},{"issue":"6","key":"582_CR21","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1634\/stemcells.2006-0709","volume":"25","author":"D Baksh","year":"2007","unstructured":"Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25(6):1384\u201392.","journal-title":"Stem Cells"},{"issue":"9","key":"582_CR22","doi-asserted-by":"crossref","first-page":"17986","DOI":"10.3390\/ijms140917986","volume":"14","author":"HJ Jin","year":"2013","unstructured":"Jin HJ, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci. 2013;14(9):17986\u20138001.","journal-title":"Int J Mol Sci"},{"key":"582_CR23","doi-asserted-by":"crossref","unstructured":"Dziadosz M, Basch RS, and Young BK. Human amniotic fluid: a source of stem cells for possible therapeutic use. Am J Obstet Gynecol. 2016.","DOI":"10.1016\/j.ajog.2015.12.061"},{"issue":"1","key":"582_CR24","first-page":"55","volume":"30","author":"D Bottai","year":"2012","unstructured":"Bottai D, et al. Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations. Restor Neurol Neurosci. 2012;30(1):55\u201368.","journal-title":"Restor Neurol Neurosci"},{"key":"582_CR25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13287-015-0204-0","volume":"6","author":"AA Schiavo","year":"2015","unstructured":"Schiavo AA, et al. Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia. Stem Cell Res Ther. 2015;6:209.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"582_CR26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijgo.2008.06.012","volume":"103","author":"Q You","year":"2008","unstructured":"You Q, et al. Isolation of human mesenchymal stem cells from third-trimester amniotic fluid. Int J Gynaecol Obstet. 2008;103(2):149\u201352.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"582_CR27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/14653240802716590","volume":"11","author":"A Tormin","year":"2009","unstructured":"Tormin A, et al. Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profiling of functionally defined MSC subsets. Cytotherapy. 2009;11(2):114\u201328.","journal-title":"Cytotherapy"},{"issue":"6","key":"582_CR28","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/01.TP.0000133305.81823.2A","volume":"78","author":"N Ahrens","year":"2004","unstructured":"Ahrens N, et al. Mesenchymal stem cell content of human vertebral bone marrow. Transplantation. 2004;78(6):925\u20139.","journal-title":"Transplantation"},{"issue":"19","key":"582_CR29","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1093\/bioinformatics\/btq431","volume":"26","author":"BS Carvalho","year":"2010","unstructured":"Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26(19):2363\u20137.","journal-title":"Bioinformatics"},{"issue":"10","key":"582_CR30","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80.","journal-title":"Genome Biol"},{"key":"582_CR31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/0-387-29362-0_23","volume-title":"Bioinformatics and Computational Biology Solutions using R and Bioconductor","author":"GK Smyth","year":"2005","unstructured":"Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer; 2005. p. 397\u2013420."},{"key":"582_CR32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/1471-2164-9-488","volume":"9","author":"T Hulsen","year":"2008","unstructured":"Hulsen T, de Vlieg J, Alkema W. BioVenn\u2014a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics. 2008;9:488.","journal-title":"BMC Genomics"},{"issue":"7","key":"582_CR33","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/stem.657","volume":"29","author":"NB Woods","year":"2011","unstructured":"Woods NB, et al. Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines. Stem Cells. 2011;29(7):1158\u201364.","journal-title":"Stem Cells"},{"key":"582_CR34","doi-asserted-by":"crossref","unstructured":"Renoux VM, et al. Identification of a Human Natural Killer Cell Lineage-Restricted Progenitor in Fetal and Adult Tissues. Immun. 2015;43(2):394\u2013407.","DOI":"10.1016\/j.immuni.2015.07.011"},{"issue":"6","key":"582_CR35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.celrep.2012.04.009","volume":"1","author":"A Kirkeby","year":"2012","unstructured":"Kirkeby A, et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 2012;1(6):703\u201314.","journal-title":"Cell Rep"},{"issue":"6","key":"582_CR36","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/humrep\/deh279","volume":"19","author":"MS Tsai","year":"2004","unstructured":"Tsai MS, et al. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004;19(6):1450\u20136.","journal-title":"Hum Reprod"},{"issue":"4","key":"582_CR37","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.2353\/ajpath.2010.091245","volume":"177","author":"PV Hauser","year":"2010","unstructured":"Hauser PV, et al. Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol. 2010;177(4):2011\u201321.","journal-title":"Am J Pathol"},{"issue":"3","key":"582_CR38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1091\/mbc.E04-10-0949","volume":"16","author":"AC Boquest","year":"2005","unstructured":"Boquest AC, et al. Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell. 2005;16(3):1131\u201341.","journal-title":"Mol Biol Cell"},{"key":"582_CR39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2164-8-70","volume":"8","author":"B Kulterer","year":"2007","unstructured":"Kulterer B, et al. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics. 2007;8:70.","journal-title":"BMC Genomics"},{"issue":"9","key":"582_CR40","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1582-4934.2010.01180.x","volume":"15","author":"MG Roubelakis","year":"2011","unstructured":"Roubelakis MG, et al. In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med. 2011;15(9):1896\u2013913.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"582_CR41","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.yexcr.2008.11.013","volume":"315","author":"A Apel","year":"2009","unstructured":"Apel A, et al. Suitability of human mesenchymal stem cells for gene therapy depends on the expansion medium. Exp Cell Res. 2009;315(3):498\u2013507.","journal-title":"Exp Cell Res"},{"issue":"2","key":"582_CR42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.stemcr.2015.12.009","volume":"6","author":"A Kyttala","year":"2016","unstructured":"Kyttala A, et al. Genetic variability overrides the impact of parental cell type and determines iPSC differentiation potential. Stem Cell Rep. 2016;6(2):200\u201312.","journal-title":"Stem Cell Rep"},{"issue":"11","key":"582_CR43","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.15252\/emmm.201505301","volume":"7","author":"M Ackermann","year":"2015","unstructured":"Ackermann M, et al. Lost in translation: pluripotent stem cell-derived hematopoiesis. EMBO Mol Med. 2015;7(11):1388\u2013402.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"582_CR44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.cr.7310043","volume":"16","author":"P Bossolasco","year":"2006","unstructured":"Bossolasco P, et al. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res. 2006;16(4):329\u201336.","journal-title":"Cell Res"},{"issue":"1","key":"582_CR45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nbt1274","volume":"25","author":"P Coppi De","year":"2007","unstructured":"De Coppi P, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25(1):100\u20136.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"582_CR46","doi-asserted-by":"crossref","first-page":"e0123350","DOI":"10.1371\/journal.pone.0123350","volume":"10","author":"L Li","year":"2015","unstructured":"Li L, et al. Characteristics of human amniotic fluid mesenchymal stem cells and their tropism to human ovarian cancer. PLoS One. 2015;10(4):e0123350.","journal-title":"PLoS One"},{"issue":"7","key":"582_CR47","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/humrep\/deg279","volume":"18","author":"AR Prusa","year":"2003","unstructured":"Prusa AR, et al. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod. 2003;18(7):1489\u201393.","journal-title":"Hum Reprod"},{"issue":"11","key":"582_CR48","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.jpedsurg.2014.04.006","volume":"49","author":"S Vadasz","year":"2014","unstructured":"Vadasz S, et al. Second and third trimester amniotic fluid mesenchymal stem cells can repopulate a de-cellularized lung scaffold and express lung markers. J Pediatr Surg. 2014;49(11):1554\u201363.","journal-title":"J Pediatr Surg"},{"issue":"2","key":"582_CR49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molcel.2012.06.020","volume":"47","author":"CC Tsai","year":"2012","unstructured":"Tsai CC, et al. Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells. Mol Cell. 2012;47(2):169\u201382.","journal-title":"Mol Cell"},{"issue":"7346","key":"582_CR50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09915","volume":"473","author":"KJ Brennand","year":"2011","unstructured":"Brennand KJ, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature. 2011;473(7346):221\u20135.","journal-title":"Nature"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-017-0582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T07:29:29Z","timestamp":1503646169000},"score":1,"resource":{"primary":{"URL":"http:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-017-0582-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,25]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1186\/s13287-017-0582-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,25]]},"article-number":"190"}}